Group One Trading
MLNT

Group One Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Group One Trading’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,600
Closed -$22K – 6127
2019
Q4 		$22K Buy
40,600
+38,700
+2,037% +$93.8K ﹤0.01% 4348
2019
Q3 		$7K Sell
1,900
-22,100
-92% -$79.6K ﹤0.01% 4704
2019
Q2 		$160K Buy
+24,000
New +$91.4K ﹤0.01% 3022
2019
Q1 		– Sell
-400
Closed -$2K – 5685
2018
Q4 		$2K Sell
400
-320
-44% -$4.09K ﹤0.01% 4694
2018
Q3 		$14K Buy
720
+20
+3% +$506 ﹤0.01% 4552
2018
Q2 		$22K Buy
700
+360
+106% +$13K ﹤0.01% 4334
2018
Q1 		$13K Sell
340
-2,300
-87% -$151K ﹤0.01% 4247
2017
Q4 		$209K Buy
+2,640
New +$195K ﹤0.01% 2899

Group One Trading's MLNT Position: Q1 2020 in Review

Group One Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 33,406 shares — an estimated $18K sold.

Group One Trading first reported a position in MLNT in Q2 2018 and held it in 6 quarters. The position peaked at $166K in Q3 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

  • Group One Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 33,406 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $18K.
  • Group One Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Group One Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $166K in Q3 2019.
  • 2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.